Agios Sets Feb. 1, 2027 PDUFA Date for Mitapivat sNDA
The PDUFA goal date for Agios Pharmaceuticals’ mitapivat sickle cell disease supplemental new drug application is Feb. 1, 2027.
The PDUFA goal date for Agios Pharmaceuticals’ mitapivat sickle cell disease supplemental new drug application is Feb. 1, 2027.